Company Description
Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on...
Key Halozyme Financials
| Company Type | Public - NASDAQ (GM): HALO Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $3.8 |
| 2006 Employees | 40 |
More Halozyme Financials (10 pages)
Latest Halozyme Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Halozyme's competition across multiple industries
Top Halozyme Competitors
Sponsored Links
The Business DirectoryHalozyme Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Kenneth J. (Ken) Kelley | Network | E-mail |
| President, CEO, and Director | Jonathan E. Lim | Network | E-mail |
| VP and CFO | David A. Ramsay | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Halozyme News
- BioWorld Today October 10, 2008 [BioWorld Today] (10 Oct 2008 00:01:00 EDT)
- FirstAlert: 7:30 A.M.-5 P.M. Investrend / Bestcalls [InvesTrend] (07 Oct 2008 00:01:00 EDT)
- Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development [Diabetes Week] (06 Oct 2008 00:01:00 EDT)
Sponsored Opportunity





